Government may suspend sale of drugs banned in major global drug markets

摘要

India plans to suspend sale of medicines that are banned in one of the six major global drug markets for harmful side-effects. According to Health Ministry officials, if a drug is banned by the US, UK, Canada, Japan, European Union or Australia, its sales will be stopped in India until clinical data proves that it will not have adverse effect on patients in the country. These embargoes will be triggered by future action of international regulators, and will not automatically apply to drugs that have already been banned in the developed countries.